Worst performer was SBTX:SkinBioTherapeutics which is up and down by big margins every week. This week it dropped 9% but is still just about in profit.
ARL:Atlantis Resources gave up most of the gains since their suspension was lifted, dropping 8% and now back to a loss of 46%.
IQE:IQE is still getting hammered so looks like I may have done the right thing selling most of my holding. They dropped 6% this week and are now down by 19% in my SIPP.
Very few big risers this week, but as one of them was OPTI:Optibiotix climbing 6%, this meant I didn't need much more to have a good week.
Share of the Week was rather unexpected. TND:Tandem Group is my most illiquid share and somebody bought a few, resulting in an 11% climb. These are only 22% down now, but with a pe ratio of just 4.6 they should be much, much higher than they are.
Still in the red but getting close again
There ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £11.13 | +£4.02 | |
| Portfolio cost | £52,236.06 | +£361.57 | |
| Portfolio sell value (bid price - commission) | £48,133.36 | (-7.9%) | +£1,345.23 |
| Potential profits | £2,313.65 | +£636.78 | |
| Yr 3 Dividends | £44.15 | +£0 | |
| Yr 3 Profit from sales | £8,387.31 | +£353.54 | |
| Yr 3 Average monthly cash profit | £846.28 | (19.4%) | +£16.33 |
| Total Dividends | £1,223.20 | +£0 | |
| Total Profit from sales | £15,099.81 | +£353.54 | |
| Average monthly cash profit | £477.08 | (11%) | +£7.23 |
| (Sold stocks profit + Dividends - Fees / Months) |
The top-slice of VRS:Versarien profits accounts for the £353 sales profit and improvement of long-term monthly performance to 11%. The proceeds were re-invested in CEY:Centamin which hasn't borne fruit yet, although VRS:Versarien did end the week lower than when I sold them, so the timing was ok as long as they don't shoot up next week. The increase in potential profits is mainly OPTI:Optibiotix and would have been more without the big drop in SBTX:SkinBioTherapeutics robbing some of them.
Almost back to where we were a few weeks ago, but still with a big gap to make up.
The SIPP looks like this after week 131
| Weekly Change | |||
| Cash | £235.54 | +£0 | |
| Portfolio cost | £27,612.67 | +£0 | |
| Portfolio sell value (bid price - commission) | £28,938.87 | (4.8%) | +£909.37 |
| Potential profits | £3,048.45 | +£953.35 | |
| Yr 3 Dividends | £205.50 | +£0 | |
| Yr 3 Profit from sales | £1,619.73 | +£0 | |
| Yr 3 Average monthly cash profit | £282.97 | (12.3%) | -£10.89 |
| Total Dividends | £1,121.60 | +£0 | |
| Total Profit from sales | £10,544.92 | +£0 | |
| Average monthly cash profit | £378.97 | (16.5%) | -£2.92 |
| (Sold stocks profit + Dividends - Fees / Months) |
Most of the rise was thanks to OPTI:Optibiotix, and a 3% rise in CAML:Central Asia Metals also helped. No sign of my hoped for rebound in MMX:Minds + Machines. LGEN:Legal & General have kindly crashed from 282.8p when I sold them to an offer price of 272.3p so I don't need much extra to be able to increase my holding when I buy back in - as long as they stay low for a few more weeks.
The buffer is getting a bit more healthy, but I'd be happier if the portfolio value could get above £30K again.
I'm starting to wonder if I should limit the charts to the last 12 months, and maybe just keep the long-term charts in the right hand panel. That's a good idea - I'll try it next week.
Seed Health launch their new product on 6th June which may draw the eye of a new band of OPTI:Optibiotix investors. I've also got my LGEN:Legal & General dividend to look forward to on the same day.
I'll be watching VRS:Versarien with some trepidation. I expected it to drop back to the 70p range this week but it actually sneaked up a bit instead. No sign of a rebound from CEY:Centamin so my cunning plan to get more VRS:Versarien shares may end up with me losing 25% of my holding long term. I'm still happy that I took a little bit of profit, and I kept enough to benefit nicely if they continue to climb.
I'll also be watching the price of gold more closely now I'm back in gold mines again with CEY:Centamin and PAF:Pan African Resources. Neither were purchased as particularly long term holdings, so I'll be willing the gold price higher for the next few weeks.
No comments:
Post a Comment